Global Market Presence Covis Pharma operates in over 50 countries, demonstrating a broad international footprint that presents numerous opportunities for expanding partnerships and supply chain solutions across diverse regions.

Acquisition Growth Strategy Recent acquisitions, including assets from Sanofi and AstraZeneca, highlight Covis Pharma's strategy to expand its portfolio rapidly, suggesting a need for integrated support in portfolio management, commercialization, and distribution services.

Specialized Therapeutic Focus With a focus on life-threatening conditions and chronic illnesses, Covis Pharma targets niche markets with high unmet needs, offering sales opportunities in specialized medical devices, diagnostics, and patient management solutions tailored for these conditions.

Investment Backing Supported by private equity firm Apollo Global Management, Covis Pharma has access to substantial capital resources, creating potential for large-scale partnerships, technology investments, and innovative healthcare solutions.

Product Portfolio Expansion The company's recent rights acquisitions from Sanofi and AstraZeneca point to ongoing product portfolio growth, providing opportunities to introduce complementary products, regulatory support, and market entry services to enhance their offerings.